CSOP China Healthcare Disruption Index ETF (HKG:3174)
3.916
+0.160 (4.26%)
At close: Jul 29, 2025, 4:00 PM HKT
HKG:3174 Holdings Information
HKG:3174 is an equity ETF with a total of 23 individual holdings. The top holdings are Akeso stock at 10.06%, Sino Biopharmaceutical at 9.78%, Innovent Biologics at 9.66%, WuXi AppTec at 8.81%, and WuXi Biologics at 8.71%.
Total Holdings
23
Top 10 Percentage
77.08%
Asset Class
Equity
ETF Category
Total Market
Assets
1.05B
PE Ratio
24.83
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 9926 | Akeso, Inc. | 10.06% |
2 | HKG: 1177 | Sino Biopharmaceutical Limited | 9.78% |
3 | HKG: 1801 | Innovent Biologics, Inc. | 9.66% |
4 | HKG: 2359 | WuXi AppTec Co., Ltd. | 8.81% |
5 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 8.71% |
6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 8.52% |
7 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 7.94% |
8 | HKG: 0241 | Alibaba Health Information Technology Limited | 4.93% |
9 | SFOSF | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 4.60% |
10 | HKG: 1548 | Genscript Biotech Corporation | 4.07% |
11 | LVZPF | Livzon Pharmaceutical Group Inc Class H | 3.52% |
12 | HKG: 1877 | Shanghai Junshi Biosciences Co., Ltd. | 2.96% |
13 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.92% |
14 | HKG: 2252 | Shanghai MicroPort MedBot (Group) Co., Ltd. | 2.72% |
15 | HKG: 3320 | China Resources Pharmaceutical Group Limited | 2.43% |
16 | HKG: 9995 | RemeGen Co., Ltd. | 1.77% |
17 | HKG: 2162 | Keymed Biosciences Inc. | 1.68% |
18 | HKG: 6185 | CanSino Biologics Inc. | 1.36% |
19 | HKG: 0867 | China Medical System Holdings Limited | 1.30% |
20 | HKG: 0512 | Grand Pharmaceutical Group Limited | 0.89% |
21 | HKG: 2607 | Shanghai Pharmaceuticals Holding Co., Ltd | 0.81% |
22 | n/a | Cash | 0.33% |
23 | HKG: 6639 | Arrail Group Limited | 0.25% |
As of Jul 30, 2025